Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
50 hedge funds and large institutions have $260M invested in Loxo Oncology, Inc in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 7 reducing their positions, and 7 closing their positions.
314% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 7
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
56% more capital invested
Capital invested by funds: $167M → $260M (+$93.4M)
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
2% more funds holding
Funds holding: 49 → 50 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$6.69M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$4.9M |
| 3 |
JP Morgan Chase
New York
|
+$2.27M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.82M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.59M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$2.18M |
| 3 |
DM
Deerfield Management
New York
|
-$1.93M |
| 4 |
AC
Ascend Capital
Orinda,
California
|
-$871K |
| 5 |
Goldman Sachs
New York
|
-$380K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GTC
51
Ghost Tree Capital
New York
| – | -$2.18M | -175,000 | Closed |
|
|
AC
52
Ascend Capital
Orinda,
California
| – | -$871K | -70,000 | Closed |
|
|
53
Goldman Sachs
New York
| – | -$380K | -30,547 | Closed |
|
54
California Public Employees Retirement System
Sacramento,
California
| – | -$138K | -12,532 | Closed |
|
|
SIM
55
Spark Investment Management
New York
| – | -$123K | -10,000 | Closed |
|
|
SO
56
STRS Ohio
Columbus,
Ohio
| – | -$14K | -1,200 | Closed |
|
|
TRCT
57
Tower Research Capital (TRC)
New York
| – | -$1K | -62 | Closed |
|
LOXO Hedge Fund Activity: Q2 2015 in Review
50 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q2 2015, worth a combined $260M — up 56% from $167M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LOXO positions and 7 closed out — a net gain of 1 holder — while 29 added to existing stakes and 7 trimmed.
The largest buyer was BVF Inc, adding an estimated $6.69M. The largest seller was Millennium Management, cutting an estimated $3.59M.
- 50 institutional investors held Loxo Oncology, Inc (LOXO) as of Q2 2015, up from 49 in Q1 2015.
- Funds reported $260M of Loxo Oncology, Inc stock for Q2 2015, up 56% quarter-over-quarter.
- 8 funds opened new Loxo Oncology, Inc positions in Q2 2015 and 7 closed out, a net change of +1 holder.
- The largest Loxo Oncology, Inc buyer in Q2 2015 was BVF Inc, an estimated $6.69M added.
- The largest Loxo Oncology, Inc seller in Q2 2015 was Millennium Management, an estimated $3.59M sold.
Based on aggregated 13F filings for Q2 2015.